Enanta Pharmaceuticals Inc (ENTA)
Cash & Short-Term Investments
$189.51M
Quarterly · Period ending: · USD
ENTA Cash & Short-Term Investments
Latest reported$189.51Mperiod ending
Latest reported$189.51Mperiod ending
ENTA Quarterly Cash & Short-Term Investments ($23.33M → $189.51M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
ENTA cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 189,506,000 | |
| 163,774,000 | |
| 185,849,000 | |
| 188,864,000 | |
| 204,111,000 | |
| 193,375,000 | |
| 216,691,000 | |
| 248,186,000 | |
| 230,085,000 | |
| 300,310,000 | |
| 337,151,000 | |
| 369,910,000 | |
| 386,585,000 | |
| 210,084,000 | |
| 214,470,000 | |
| 249,232,000 | |
| 253,288,000 | |
| 280,327,000 | |
| 259,052,000 | |
| 244,002,000 | |
| 256,824,000 | |
| 375,947,000 | |
| 386,196,000 | |
| 386,649,000 | |
| 370,000,000 | |
| 355,255,000 | |
| 373,785,000 | |
| 335,236,000 | |
| 389,248,000 | |
| 370,157,000 | |
| 345,788,000 | |
| 308,730,000 | |
| 273,227,000 | |
| 256,723,000 | |
| 220,442,000 | |
| 223,669,000 | |
| 192,015,000 | |
| 175,573,000 | |
| 209,358,000 | |
| 210,084,000 | |
| 218,465,000 | |
| 220,422,000 | |
| 180,019,000 | |
| 145,205,000 | |
| 154,286,000 | |
| 165,472,000 | |
| 104,022,000 | |
| 90,764,000 | |
| 95,887,000 | |
| 94,770,000 | |
| 91,895,000 | |
| 101,480,000 | |
| 94,546,000 | |
| 109,111,000 | |
| 45,485,000 | |
| 43,762,000 | |
| 46,764,000 | |
| 23,329,000 |